Electric modulation of sympathetic nervous system

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8024035
APP PUB NO 20070225768A1
SERIAL NO

11804449

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method is described for the treatment of obesity or other disorders, by electrical activation or inhibition of the sympathetic nervous system. This activation or inhibition can be accomplished by electrically stimulating the greater splanchnic nerve or other portion of the sympathetic nervous system using an implantable pulse generator. This nerve activation can result in reduced food intake and increased energy expenditure. Reduced food intake may occur through a variety of mechanisms that reduce appetite and cause satiety. Increased adrenal gland hormone levels will result in increased energy expenditure. Fat and carbohydrate metabolism, which are also increased by sympathetic nerve activation, will accompany the increased energy expenditure.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ADVANCED NEUROMODULATION SYSTEMS, INC.;LEPTOS BIOMEDICAL, INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dobak,, III John D La Jolla, US 25 568

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation